In STAM NASH mice livers, PPARs inhibition was not evident and CK8 and CK18 levels were high, indicating the existence of major differences in human and mouse mechanisms of NASH pathogenesis. This evidence concerns the gene KRT18 and metabolic dysfunction-associated steatohepatitis.